Daunosamnyl-daunorubicin

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 597594

CAS#: 28008-54-0

Description: Daunosamnyl-daunorubicin is an antibody conjugate.


Chemical Structure

img
Daunosamnyl-daunorubicin
CAS# 28008-54-0

Theoretical Analysis

MedKoo Cat#: 597594
Name: Daunosamnyl-daunorubicin
CAS#: 28008-54-0
Chemical Formula: C33H40N2O12
Exact Mass: 656.26
Molecular Weight: 656.680
Elemental Analysis: C, 60.36; H, 6.14; N, 4.27; O, 29.24

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Daunosamnyl-daunorubicin;

IUPAC/Chemical Name: (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-(((2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione

InChi Key: HCMSUFXIFYKIOL-RPYJURNCSA-N

InChi Code: InChI=1S/C33H40N2O12/c1-12-27(37)17(34)8-22(44-12)47-32-13(2)45-21(9-18(32)35)46-20-11-33(42,14(3)36)10-16-24(20)31(41)26-25(29(16)39)28(38)15-6-5-7-19(43-4)23(15)30(26)40/h5-7,12-13,17-18,20-22,27,32,37,39,41-42H,8-11,34-35H2,1-4H3/t12-,13-,17-,18-,20-,21-,22-,27+,32+,33-/m0/s1

SMILES Code: COc1c2c(C(c3c(C2=O)c(O)c4c(C[C@](C[C@@H]4O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O)N)N)(C(C)=O)O)c3O)=O)ccc1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 656.68 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Gesson JP, Jacquesy JC, Mondon M, Petit P, Renoux B, Andrianomenjanahary S, Dufat-Trinh Van H, Koch M, Michel S, Tillequin F, et al. Prodrugs of anthracyclines for chemotherapy via enzyme-monoclonal antibody conjugates. Anticancer Drug Des. 1994 Oct;9(5):409-23. PubMed PMID: 7945725.

2: Arcamone FM. Sabarubicin. Top Curr Chem. 2008;283:171-89. doi: 10.1007/128_2007_1. PubMed PMID: 23605632.

3: Kaptein SJ, De Burghgraeve T, Froeyen M, Pastorino B, Alen MM, Mondotte JA, Herdewijn P, Jacobs M, de Lamballerie X, Schols D, Gamarnik AV, Sztaricskai F, Neyts J. A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro. Antimicrob Agents Chemother. 2010 Dec;54(12):5269-80. doi: 10.1128/AAC.00686-10. Epub 2010 Sep 13. PubMed PMID: 20837762; PubMed Central PMCID: PMC2981273.

4: Arcamone F, Animati F, Capranico G, Lombardi P, Pratesi G, Manzini S, Supino R, Zunino F. New developments in antitumor anthracyclines. Pharmacol Ther. 1997 Oct-Dec;76(1-3):117-24. Review. PubMed PMID: 9535173.

5: Yoshimoto A, Fujii S, Johdo O, Kubo K, Ishikura T, Naganawa H, Sawa T, Takeuchi T, Umezawa H. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism. J Antibiot (Tokyo). 1986 Jul;39(7):902-9. PubMed PMID: 3759649.

6: Temperini C, Messori L, Orioli P, Di Bugno C, Animati F, Ughetto G. The crystal structure of the complex between a disaccharide anthracycline and the DNA hexamer d(CGATCG) reveals two different binding sites involving two DNA duplexes. Nucleic Acids Res. 2003 Mar 1;31(5):1464-9. PubMed PMID: 12595554; PubMed Central PMCID: PMC149838.

7: Kimura Y, Matsumoto T, Suzuki M, Terashima S. Synthesis and antitumor activity of optically active (+)-9-O-alpha-L-daunosaminyl-4-demethoxydaunorubicin. J Antibiot (Tokyo). 1985 Sep;38(9):1277-9. PubMed PMID: 4066509.

8: Mitscher LA, Gill H, Filppi JA, Wolgemuth RL. Total chemical synthesis and antitumor evaluation of the 9-aza analogue of N-(trifluoroacetyl)-4-demethoxydaunomycin. J Med Chem. 1986 Jul;29(7):1277-81. PubMed PMID: 3806577.

9: Smith TH, Fujiwara AN, Henry DW. Adriamycin analogues. 2. Synthesis of 13-deoxyanthracyclines. J Med Chem. 1978 Mar;21(3):280-3. PubMed PMID: 628003.